PEX12 — Peroxisomal Biogenesis Factor 12

The PEX12 gene provides instructions for making a protein that is crucial for the formation and function of peroxisomes. Peroxisomes are small compartments within cells that act like recycling centers, breaking down certain types of fats and toxic substances. Without properly functioning peroxisomes, harmful substances like very long-chain fatty acids build up in the body's cells and tissues. When a person inherits two mutated copies of the PEX12 gene, it causes a condition known as Zellweger spectrum disorder. This buildup of toxic substances severely damages the brain, liver, and other organs. In the eyes, it can lead to retinal dystrophy and progressive vision loss. Patients may also experience hearing loss, severe muscle weakness (hypotonia), developmental delays, and liver problems. The severity of the disease depends on the specific type of mutation in the PEX12 gene. Some mutations completely destroy the protein's function, leading to severe symptoms that appear shortly after birth and are often life-threatening in infancy. Other mutations allow the protein to work partially, resulting in milder symptoms and a longer lifespan, though patients still require comprehensive medical care to manage their symptoms.

Gene description: The PEX12 gene encodes an integral peroxisomal membrane protein essential for the assembly of functional peroxisomes. Mutations in this gene disrupt peroxisome biogenesis, leading to severe metabolic disorders known as Zellweger spectrum disorders, which affect multiple organ systems including the brain, liver, and eyes.

Patient and family guide: The PEX12 gene provides instructions for making a protein that is crucial for the formation and function of peroxisomes. Peroxisomes are small compartments within cells that act like recycling centers, breaking down certain types of fats and toxic substances. Without properly functioning peroxisomes, harmful substances like very long-chain fatty acids build up in the body's cells and tissues. When a person inherits two mutated copies of the PEX12 gene, it causes a condition known as Zellweger spectrum disorder. This buildup of toxic substances severely damages the brain, liver, and other organs. In the eyes, it can lead to retinal dystrophy and progressive vision loss. Patients may also experience hearing loss, severe muscle weakness (hypotonia), developmental delays, and liver problems. The severity of the disease depends on the specific type of mutation in the PEX12 gene. Some mutations completely destroy the protein's function, leading to severe symptoms that appear shortly after birth and are often life-threatening in infancy. Other mutations allow the protein to work partially, resulting in milder symptoms and a longer lifespan, though patients still require comprehensive medical care to manage their symptoms.

Gene function: The PEX12 protein is an integral peroxisomal membrane protein that functions as a component of a retrotranslocation channel. It is required for peroxisome organization by mediating the export of the PEX5 receptor from peroxisomes to the cytosol, which is essential for peroxisomal matrix protein import.

Protein structure: PEX12 is a 359-amino acid integral peroxisomal membrane protein with a molecular mass of approximately 40 kD. It contains two membrane-spanning domains and a C-terminal C3HC4 zinc-binding RING-finger motif that extends into the cytosol.

Molecular function: PEX12 functions as a protein-ubiquitin ligase within the peroxisomal membrane. It contains a C3HC4 zinc-binding RING-finger domain that extends into the cytosol and is essential for its activity. PEX12 interacts with other peroxins, such as PEX5 and PEX10, and facilitates the PEX4-dependent monoubiquitination of the PEX5 receptor. This ubiquitination is a critical step in the recycling of PEX5 from the peroxisome back to the cytosol, enabling continuous cycles of peroxisomal matrix protein import.

Mutation spectrum: The mutation spectrum of PEX12 includes frameshift mutations (insertions and deletions), nonsense mutations leading to premature termination, splice site mutations, and missense mutations. Severe truncating mutations typically result in classic Zellweger syndrome, while certain missense mutations (e.g., S320F, R91S) are associated with milder, atypical phenotypes.

Clinical significance: Mutations in the PEX12 gene cause peroxisome biogenesis disorders (PBDs) in the Zellweger spectrum, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. These mutations lead to defective peroxisomal matrix protein import, resulting in the accumulation of very long-chain fatty acids and bile acid precursors. This causes severe neurological impairment, hypotonia, liver dysfunction, sensorineural hearing loss, and retinal dystrophy. Severe mutations result in early lethality, while milder missense mutations can lead to prolonged survival with variable clinical presentations.

Inheritance: Autosomal Recessive

Chromosomal location: 17q12

Research and therapeutic approaches: Currently, there is no curative therapy for PEX12-related Zellweger spectrum disorders, and management is primarily supportive. Multidisciplinary care involves neurology, hepatology, and ophthalmology to address specific symptoms. Experimental approaches under research include gene therapy using recombinant adeno-associated viruses to restore PEX gene function, and allogeneic hematopoietic stem cell transplantation, though these are not yet standard clinical treatments.